An Unusual Case of Growth Hormone Receptor Deficiency Syndrome

Laron Z Pertzelan A Mannheimer S . Genetic Pituitary dwarfism with high serum concentration of growth hormone: A new inborn error of metabolism? Isr J Med Sci 1966; 2: 152–5

Amselem S Duquesnoy P Attree O Novelli G Bousnina S Postel-Vinay MC . Laron dwarfism and mutation of the growth hormone receptor gene. N Engl J Med 1989; 321: 989–95

Godowski PJ Leung DW Meacham LR Galgani JP Hellmiss R Keret R . Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc Natl Acad Sci USA 1989; 86: 8083–7

Rosenbloom AL Savage MO Blum WF Guevara-Aquirre J Rosenfeld RG . Clinical and biochemical characteristics of growth hormone receptor deficiency (Laron syndrome). Acta Paediatr 1992; 383(suppl): 121–4

Laron Z Pertzelan A Karp M Kowadlo-Silbergeld A Daughaday W . Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone. Measurement of sulfation factor, metabolic and linear growth responses. J Clin Endocrinol Metab 1971; 33: 332–42

Guevara-Aquirre J Rosenbloom AL Vaccarello MA . Growth hormone receptor deficiency (Laron syndrome): Clinical and genetic characteristics. Acta Paediatr 1991; 377(suppl): 96–103

Laron Z Klinger B Blum WF Silbergeld A Ranke MB . IGF binding protein 3 in patients with Laron type dwarfism: Effect of exogenous rIGF-I. Clin Endocrinol 1992; 36: 301–4

Leung DW Spencer SA Cachianes G Hammonds RG Collins C Henzel WJ . Growth hormone receptor and serum binding protein: Purification, cloning and expression. Nature 1987; 330: 537–43

Baumann G Shaw MA Winter RJ . Absence of the plasma growth hormone-binding protein in Laron-type dwarfism. J Clin Endocrinol Metab 1987; 65: 814–6

Daughaday WH Trivedi B . Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism). Proc Natl Acad Sci USA 1987; 84: 4636–40

Buchanan CR Maheshwari HG Norman MR Morrell EJ Preece MA . Laron-type dwarfism with apparently normal high affinity serum growth hormone binding protein. Clin Endocrinol 1991; 35: 179–85

Duquesnoy P Sobrier M Duriez B Dastot F Buchanan C Savage M . A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron Syndrome) with positive GH-binding activity by abolishing receptor homodimerization. EM BO J 1994; 13: 1386–95

Teale JD Marks V . Inappropriately elevated plasma insulin-like growth factor II in relation to suppressed insulin-like growth factor I in the diagnosis of non-islet cell tumour hypoglycaemia. Clin Endocrinol 1990; 33: 87–98

Baxter R Martin J . Radioimmunassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. J Clin Invest 1986; 78: 1504–12

Baxter RC Brown AS . Purification of tracer for somatomedin C radioimmunassay by hydrophobic interaction chromatography. Clin Chem 1982; 28: 485–7

Cotterill AM Holly JMP Taylor AM Davies SC Coulson VJ Preece MA . The insulin-like growth factor (IGF)-binding proteins and IGF bioactivity in Laron-type dwarfism. J Clin Endocrinol Metab 1992; 74: 56–63

Laron Z Klinger B Eshet R Kaneti H Karasik A Silbergeld A . Laron syndrome due to a postreceptor defect: Response to IGF-I treatment. Isr J Med Sci 1993; 29: 757–63